Segment and Geographical Information (Tables)

6 Months Ended

Mar. 31, 2018

Segment Reporting [Abstract]

Segment Revenue, Operating Income (Loss) and Depreciation and Amortization

The tables below present segment revenue, operating income (loss) and depreciation and amortization, as follows:

	Three Months Ended						Six Months Ended
	March 31,						March 31,
(Dollars in thousands)	2018			2017			2018			2017
Revenue:
Medical Device	$	14,052		$	12,726		$	26,826		$	26,482
In Vitro Diagnostics		5,006			4,777			9,245			8,782
Total revenue	$	19,058		$	17,503		$	36,071		$	35,264
Operating income (loss):
Medical Device	$	232		$	1,504		$	(157	)	$	5,223
In Vitro Diagnostics		2,423			2,236			4,093			3,692
Total segment operating income		2,655			3,740			3,936			8,915
Corporate		(2,130	)		(2,063	)		(4,044	)		(3,970	)
Total operating income (loss)	$	525		$	1,677		$	(108	)	$	4,945
Depreciation and amortization:
Medical Device	$	1,324		$	1,053		$	2,596		$	2,058
In Vitro Diagnostics		100			103			190			206
Corporate		162			172			320			346
Total depreciation and amortization	$	1,586		$	1,328		$	3,106		$	2,610